Skin Cancer Evaluation. Simplified.
- Tweets 542
- Following 254
- Followers 212
- Likes 68
The only FDA-cleared automated solution for skin cancer detection, and it fits in your hand. DermaSensor uses AI + Elastic Scattering Spectroscopy to help physicians assess lesions at the point of care. Objective. Fast. Built for real practices. Request a demo, link in bio.
12
Before schedules fill up, get your annual physicals, screenings, and skin checks on the calendar.
A little planning now = easier preventive care before the holiday rush.
Need a provider? Use the DermaSensor Physician Finder (link in bio) to find one near you.
1
1
42
For cancer survivors, staying proactive about skin health brings extra reassurance. In this patient testimonial, hear how simple the DermaSensor assessment felt and how it added confidence to their skin check. Find a physician near you at the link in bio.
13
Summer's over, but sun damage can linger. As fall physicals ramp up, make skin checks part of the visit, especially when a suspicious lesion comes up.
DermaSensor pairs elastic scattering spectroscopy + AI for an immediate result at point of care.
dermasensor.com
22
Primary care is often where suspicious skin lesions are first noticed. DermaSensor brings objective, real-time data into the exam room to support risk assessment when it matters most. Learn more via the link in bio.
1
2
25
More practices are adding DermaSensor, and the clinical value speaks for itself: 96% sensitivity, FDA cleared, non-invasive, immediate results. Objective skin cancer risk data at the point of care, without slowing down the visit. Link in bio to learn more.
1
17
Summer's ending, but UV damage doesn't. Repeated sunburns raise skin cancer risk, including melanoma. Watch for spots that are new, changing, or concerning. DermaSensor gives clinicians an AI-powered, non-invasive tool for real-time skin cancer risk assessment. Link in bio.
23
Health equity matters in skin cancer detection. DermaSensor's AI analyzes 47 wavelengths per lesion. DERM-SUCCESS study: 95.5% sensitivity overall, 96.5% in Fitzpatrick I-III, 92.2% in IV-VI. Innovation + evidence = equitable care. Link in bio.
#DermaSensor #HealthEquity
19
Hear it directly from the physicians using DermaSensor. Providers across the country share how it boosts confidence assessing suspicious lesions, strengthens clinical decision-making, and creates clearer patient conversations.
Link in bio to learn more or request a demo.
27
September means busier schedules and faster visits. DermaSensor gives providers an AI-powered, non-invasive tool to assess suspicious skin lesions in real time, fitting into clinical workflow without adding complexity. Learn more about DermaSensor.
20
September is Skin Care Awareness Month, a reminder to make skin health part of everyday care. Check your skin regularly and talk to your provider about anything new or changing. Providers: see how DermaSensor supports skin cancer risk assessment at the point of care. Link in bio.
17
Proud to be named a CIO Bulletin Leading Company to Watch 2026! This honor reflects our team's work advancing AI-powered skin health tech and expanding point-of-care access. Grateful for the journey and excited for what's next.
#DermaSensor #MedTech #DigitalHealth #AI
14
Expanding access. Advancing care.
We've announced four new strategic partnerships bringing DermaSensor's AI-powered skin cancer technology to more healthcare providers, from primary care to federal health systems and national distribution.
Learn more at DermaSensor.com.
11
AI in skin cancer detection raises real questions. The truth: it's not replacing clinicians; it's supporting them with real-time insights at the point of care. DermaSensor helps assess suspicious lesions with non-invasive tech built for everyday workflows. dermasensor.com
27
Congrats to Cody Simmons, CEO of DermaSensor, on being named a 2026 Titan 100 Honoree, recognizing Miami's top CEOs. His leadership continues to drive our mission to expand access to AI-powered skin cancer detection tools for clinicians. Proud of this well-deserved recognition!
17
DermaSensor showed 95.5% sensitivity in both the DERM-SUCCESS and DERM-ASSESS III studies, supporting more confident skin cancer risk assessments at the point of care. It supports, not replaces, clinical judgment for non-dermatologist physicians.
SOURCE: dermasensor.com
1
42
"I never thought skin cancer could happen to me… until it did."
Max's PCP used DermaSensor to catch what could've been missed. Diagnosed with basal cell carcinoma - early enough to act.
Don't wait. Ask about DermaSensor or find a physician at dermasensor.com.
51
Join us Aug 12 at 3PM ET for an AAPC-accredited webinar on documenting & coding dermal neoplasms in primary care, presented by TRG, sponsored by DermaSensor.
34
The new DermaSensor website is officially live.
Explore clinical studies, educational materials, reimbursement support, product info, and request a demo — all in one place.
Visit dermasensor.com
41
10 years of DermaSensor, and we're just getting started.
AI-powered, non-invasive technology helping PCPs assess suspicious moles and lesions at the point of care, bringing more confidence and efficiency to everyday patient visits.
Request a demo at dermasensor.com.
30
Primary care providers are often the first stop for suspicious skin concerns.
DermaSensor brings real-time, non-invasive support into every visit, the first and only FDA-cleared device for all three major skin cancer types.
Learn more at Dermasensor.com.
17
AI-powered. FDA-cleared. Non-invasive.
DermaSensor helps primary care providers assess suspicious skin lesions in real time—fitting naturally into your existing workflow.
Ready to see it in action? Request a demo → dermasensor.com/requestdemo
24
DermaSensor is entering a new global chapter.
With Class IIb CE Mark and an active NHS collaboration, this milestone expands access to AI-powered, non-invasive skin cancer assessment technology.
Request a demo at dermasensor.com.
26
DermaSensor gives clinicians real-time, non-invasive skin lesion support right at the point of care — no referral required to take that first step.
Request a demo: dermasensor.com/requestdemo
32
FDA just approved the first new sunscreen ingredient in 20+ years. Bemotrizinol offers broad-spectrum UVA/UVB protection with low skin absorption.
Better sunscreen + early detection = your best defense. Get suspicious spots checked. 🔗 dermasensor.com
17
Skin cancer statistics are rising. Practices need tools that keep up.
DermaSensor supports clinicians with AI-powered, non-invasive technology to assess suspicious lesions at the point of care.
Request a demo at dermasensor.com.
20
Melanoma doesn't always look the way you'd expect, with different shapes, sizes, colors, and locations.
Don't guess. Get checked with DermaSensor's non-invasive technology.
Find a DermaSensor Physician near you at dermasensor.com.
19
DermaSensor at the World Health Expo Conference.
Our CEO, Cody Simmons, joined the panel "Cracking the Enterprise Health System: How to Sell and Scale in 2026."
Learn more at dermasensor.com.
24
Q&A with DermaSensor™ CEO & Co-Founder Cody Simmons 🎙️
Nearly 10 years in, Cody shares the vision behind DermaSensor™, making skin cancer risk assessment accessible in everyday care. The future is just getting started. 🔬
🔗 dermasensor.com
18
Summer means more UV exposure ☀️
Skin cancer isn't just from beach days — everyday sun adds up over time.
Regular skin checks and catching changing lesions early can make a major difference.
Find a physician at DermaSensor.com.
8
Primary care physicians are often the first to spot suspicious skin lesions.
DermaSensor™ brings AI-powered technology to the point of care to support earlier skin cancer assessments. CCO Carolyn Walsh explains how. 🔬
Learn more: dermasensor.com
20
AI-powered, non-invasive skin cancer risk assessment — built for real-world clinical workflows.
Backed by clinical evidence. Designed for everyday practice.
Request a demo at dermasensor.com.
14
Award-winning AI meets real-world impact.
DermaSensor™ brings non-invasive, AI-powered skin cancer risk assessment to the point of care — supporting more confident clinical evaluations.
Learn more at dermasensor.com.
13
Tanning is trending — but so is the risk.
Melanoma rates continue to rise, especially in women under 50.
☀️ Wear sunscreen.
🔎 Monitor your skin.
📅 Get regular skin checks.
Find a DermaSensor provider near you on our website.
15
Hear directly from Dr. Joseph Gomes on how DermaSensor™ has enhanced his practice — from real-time clinical decision-making to streamlined patient care workflows.
Learn more at dermasensor.com.
19
Healthcare providers evaluate suspicious skin lesions every day. DermaSensor™ brings AI-powered, non-invasive skin cancer risk assessment directly to the point of care — built for real clinical environments. Learn more at dermasensor.com.
1
14
From a question in 2009 to an AI-powered handheld device for point-of-care skin cancer assessment. DermaSensor™ CEO Cody Simmons shares the story behind the mission. 🔬
Learn more at dermasensor.com
19
Summer = more UV exposure ☀️ and more reasons to stay proactive about skin health.
Patients: Book your summer skin check.
Providers: learn how DermaSensor™ fits your workflow at dermasensor.com.
9
Immediate, objective results at the point of care — that's why providers are integrating DermaSensor™ into their workflow.
AI-powered. Non-invasive. Built for primary care.
See how it can support your practice → dermasensor.com
1
51
In ~30 seconds, DermaSensor™ uses AI-powered spectroscopy to assess suspicious skin lesions at the point of care — beyond what the eye alone can see.
Fast. Objective. Built for your workflow.
Visit dermasensor.com to request a demo.
1
11
Evaluating skin lesions can be time-consuming and unclear. DermaSensor™ uses AI to detect suspicious lesions in seconds at the point of care.
Request a demo: dermasensor.com/requestdemo/
14
This is your sign to stop ignoring that spot and get your skin checked.
DermaSensor™ helps providers assess lesions right at the point of care.
Find a physician near you: dermasensor.com/find-a-physi…
Request a demo: dermasensor.com/requestdemo/
8
Skin cancer risk accumulates over years, and many changes go unnoticed until it's too late. Nearly 9,500 people in the U.S. are diagnosed daily.
Stay ahead: find a DermaSensor™ physician: dermasensor.com/find-a-physi…
7
That spot you've been thinking about? Get it checked. Simple, quick, and peace of mind.
Find a DermaSensor™ physician near you at dermasensor.com/find-a-physi…
For providers - request a demo at dermasensor.com/requestdemo/
11
It's Skin Cancer Awareness Month. Routine care is where detection starts.
DermaSensor™ provides fast, non-invasive assessments during everyday visits. Prioritize your skin health.
Find a provider: dermasensor.com/find-a-physi…
12
DermaSensor™ brings real-time skin cancer assessment into the exam room. Immediate, non-invasive insight at the point of care. Better data leads to better decisions and better outcomes.
Request a demo: dermasensor.com/requestdemo/
17
DermaSensor™ is now used during annual checkups at Family Medical Group - adding quick, non-invasive skin assessments in minutes. Easy to use. Built for real clinical settings. Would you integrate it into your routine exams?
🔗 Learn more: dermasensor.com
29
96% sensitivity, 50% fewer missed skin cancers. FDA pivotal studies show DermaSensor™ helps physicians make more accurate decisions at the point of care.
Request a demo: dermasensor.com/requestdemo/
Read More: dermasensor.com/resource/
29
Melanoma Monday 🖤 Early detection saves lives. Regular skin exams are essential. With DermaSensor™, providers can assess suspicious lesions quickly and non-invasively during a visit.
Prioritize your skin's health. Find a physician: dermasensor.com/find-a-physi…
33
Thank you to everyone who visited the DermaSensor booth at #AAD2026. The conversations around early skin cancer detection and the importance point-of-care technology were incredible.
Learn more: hubs.li/Q0492D1d0
#Dermatology #SkinCancer #MedTech
1
1
1
70